glp 1 dual agonist The Emerging Role of GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Frontiers | GLP-1/GIP dual agonist
Description
Competing interests No competing interests to be declared
drafted the manuscript, and all authors reviewed, edited and approved the manuscript
took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase III Attain-Maintain trial with orforglipron, a once-daily oral small molecule GLP-1 receptor agonist
26, e12953
9 , e002208 (2021)
Primary Sources 1.7.2
